Wallace Capital Management Inc. Novartis Ag Transaction History

Wallace Capital Management Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$85.54 - $94.26 $8.48 Million - $9.35 Million	-99,157 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$75.4 - $92.8 $65,371 - $80,457	-867 Reduced 0.87%	99,157 $9.05 Million
Q1 2019 May 14, 2019	BUY	$75.32 - $86.15 $46,849 - $53,585	622 Added 0.63%	100,024 $9.62 Million
Q4 2018 Feb 14, 2019	SELL	$73.66 - $82.02 $9,944 - $11,072	-135 Reduced 0.14%	99,402 $8.53 Million
Q3 2018 Nov 13, 2018	BUY	$66.94 - $77.43 $67,877 - $78,514	1,014 Added 1.03%	99,537 $8.58 Million
Q2 2018 Aug 13, 2018	BUY	$64.91 - $73.36 $197,326 - $223,014	3,040 Added 3.18%	98,523 $7.44 Million
Q1 2018 May 14, 2018	BUY	$70.39 - $84.15 $775,345 - $926,912	11,015 Added 13.04%	95,483 $7.72 Million
Q4 2017 Feb 14, 2018	BUY	$72.33 - $77.64 $51,788 - $55,590	716 Added 0.85%	84,468 $7.09 Million
Q3 2017 Nov 13, 2017	BUY	$74.14 - $77.27 $357,725 - $372,827	4,825 Added 6.11%	83,752 $7.19 Million
Q2 2017 Aug 14, 2017	BUY	N/A	78,927	78,927 $6.59 Million

1,434

138M

1.48M

1.55M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $230B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Wallace Capital Management Inc., based on Form 13F filings with the SEC.

Stay updated on Wallace Capital Management Inc. with notifications on news.